(Q37142001)

18 August 2017

1 reference

title

The role of molecular markers in predicting response to therapy in patients with colorectal cancer (English)

1 reference

18 August 2017

1 reference

Veena Shankaran

1

1 reference

18 August 2017

Kari B Wisinski

series ordinal

2

1 reference

18 August 2017

Mary F Mulcahy

series ordinal

3

1 reference

18 August 2017

Al B Benson

series ordinal

4

1 reference

18 August 2017

language of work or name

1 reference

1 January 2008

1 reference

Molecular Diagnosis and Therapy

18 August 2017

published in

1 reference

18 August 2017

volume

12

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

87-98

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03256274

18 August 2017

exact match

0 references

cites work

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

The staging of colorectal cancer: 2004 and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Adjuvant therapy in stage II colon cancer: current approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Survival of patients with stage B2 colon carcinoma. The Gastrointestinal Tumor Study Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Prognostic and predictive factors in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Clues to the pathogenesis of familial colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Genetic mapping of a locus predisposing to human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Microsatellite instability in cancer of the proximal colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Systematic review of microsatellite instability and colorectal cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Mismatch repair proficiency and in vitro response to 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Genetic instabilities in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Molecular predictors of survival after adjuvant chemotherapy for colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Molecular markers in prognosis of colorectal cancer and prediction of response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Role of genomic markers in colorectal cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: Preliminary report from an ongoing trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Predictive value of thymidylate synthase expression in resected metastases of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Molecular staging for survival prediction of colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Microarray analysis in the clinical management of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256274

Allelic loss of chromosome 18q and prognosis in colorectal cancer

21 January 2018

1 reference

12 December 2020

Adjuvant chemotherapy for colon cancer: a confusing area!

1 reference

12 December 2020

Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab

1 reference

12 December 2020

Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas.

1 reference

12 December 2020

p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site.

1 reference

12 December 2020

Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.

1 reference

12 December 2020

Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences.

1 reference

12 December 2020

Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

1 reference

12 December 2020

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer

1 reference

12 December 2020

Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab

1 reference

12 December 2020

Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin.

1 reference

12 December 2020

Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.

1 reference

12 December 2020

Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.

1 reference

12 December 2020

Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil

1 reference

12 December 2020

p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Dukes' C colon carcinoma

1 reference

12 December 2020

Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level.

1 reference

12 December 2020

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

1 reference

12 December 2020

Hereditary colorectal cancer

1 reference

12 December 2020

Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study

1 reference

12 December 2020

Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer

1 reference

12 December 2020

Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines

1 reference

12 December 2020

A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significance

1 reference

12 December 2020

Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma: implications for a standardized scoring system

1 reference

12 December 2020

Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen

1 reference

12 December 2020

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

1 reference

12 December 2020

Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03256274

1 reference

18 August 2017

1 reference